Add Company
Join Now

Esphera SynBio Revenue and Competitors

License our Company Data API

Ottawa, ON ca

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Esphera SynBio's estimated annual revenue is currently $1.9M per year.(i)
  • Esphera SynBio's estimated revenue per employee is $155,000

Employee Data

  • Esphera SynBio has 12 Employees.(i)
  • Esphera SynBio grew their employee count by 100% last year.

Esphera SynBio's People

NameTitleEmail/Phone
1
Founder, CEOReveal Email/Phone
2
Founder, CSOReveal Email/Phone
3
Manager, In Vivo OperationsReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.2M2729%$5MN/A
#2
$1.7M1122%N/AN/A
#3
$0.9M11-72%$39.4MN/A
#4
$1M13-84%$23.8MN/A
#5
$94.4M6098%N/AN/A
#6
$3.4M2210%N/AN/A
#7
$9.5M61-68%N/AN/A
#8
$18.1M11730%N/AN/A
#9
$21.7M140-6%N/AN/A
#10
$1M13-41%N/AN/A
Add Company

What Is Esphera SynBio?

Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the-shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera's versatile platform shows promise in broader immunomodulation applications.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M129%N/A
#2
$1M12N/AN/A
#3
$1M12N/AN/A
#4
$1M12N/AN/A
#5
$1.8M12N/AN/A